19 /100
LOW RISK
Score updated May 29, 2026

PYXS — Pyxis Oncology, Inc. Dilution Risk Tracker

Track PYXS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PYXS — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
10
📊 Float Risk
25
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

Watch
Minor dilution signals detected
15%
🔄 Reverse Split 30%
• 50-day avg $1.78 approaching $1 threshold
🔔 Track PYXS — Get forecast alerts →

💹 Market Data

Market Cap$112.77M
Shares Outstanding63.36M
Float40.72M
Cash$41.02M
Debt$18.26M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 32.0% shares (2025Q4 vs prior)
79 institutional holders · 35.92M shares
#1 Laurion Capital Management LP 9.59M shares
#2 Pfizer Inc 7.03M shares
#3 GordonMD Global Investments LP 4.12M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest1.99M
Days to Cover5.5
% of Float4.9%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2021
4 INSIDER TRANSACTION Mar 25, 2026
4 INSIDER TRANSACTION Mar 25, 2026
4 INSIDER TRANSACTION Mar 25, 2026
4 INSIDER TRANSACTION Mar 25, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track PYXS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking PYXS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for PYXS
📊 PYXS FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 PYXS Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.